(¿Â¶óÀÎ) 2022 Á¦ 3ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°Á : 2022-10-15±³À°ÀÏÀÚ : 2022-10-15
±³À°Àå¼Ò : (¿Â¶óÀÎ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ) 2022 Á¦ 3ȸ ½Å¼ººóÇ÷¿¬±¸È¸ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½Å¼ººóÇ÷¿¬±¸È¸
´ã´çÀÚ : °í°Áö
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ :
ksn@ksn.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-15 ¿Â¶óÀÎ 09:10~09:45 Anemia in patients with acute kidney injury ¾çÁöÇö(¼º±Õ°üÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 10-15 ¿Â¶óÀÎ 09:45~10:20 Anemia in patients with kidney transplantation ±èÈ¿»ó(¿ï»êÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 10-15 ¿Â¶óÀÎ 10:20~10:55 Dysregulation of iron metabolism in chronic kidney disease : What is implicated in functional iron deficiency? ȲÇö¼®(°æÈñÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 10-15 ¿Â¶óÀÎ 10:55~11:30 Erythropoietin Resistance : What do we know about the bad guys? À±¼¼Èñ(°Ç¾çÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 10-15 ¿Â¶óÀÎ 11:30~12:10 HIF-Prolyl Hydroxylase Inhibition for Treating Anemia in chronic kidney disease : What should we care for the safety? °í°Áö(°í·ÁÀÇ´ë ½ÅÀå³»°ú)